Overview

Sedation to Electroencephalography With Dexmedetomidine or Chloral Hydrate

Status:
Completed
Trial end date:
2013-10-01
Target enrollment:
0
Participant gender:
All
Summary
This study evaluates the use of dexmedetomidine or chloral hydrate for sedation during electroencephalography in patients with neurological disorders. The hypothesis is that this drugs provides similar changes in EEG pattern.
Phase:
Phase 3
Accepts Healthy Volunteers?
No
Details
Lead Sponsor:
Federal University of Minas Gerais
Collaborator:
Santa Casa de Misericórdia de Belo Horizonte
Treatments:
Chloral Hydrate
Dexmedetomidine
Criteria
Inclusion Criteria:

- neurological disorder

- behavior disorder

- epilepsy

Exclusion Criteria:

- cardiac disease

- respiratory disease